Aldafermin Completed Phase 1 Trials for Impaired Renal Function Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04179630Study of Aldafermin (NGM282) in Participants With Impaired Renal Function